Scott Smith, director of project management, CT, Philips Healthcare, describes low-dose CT as nearly a given in the marketplace now. What’s more important is maintaining the speed and quality of the image while using iterative reconstruction to keep the dose low.
Patient and hospital concern over CT dose has created a “perfect storm” for new products in CT, according to Gene Saragness, Philips’ EVP and CEO. Philips iDose4 has had the “fastest uptake I’ve seen in any product.” The Ingenuity CT with iDose4 was originally introduced at last year’s RSNA.
The company will put focus on its latest iDose technology at RSNA 2011.
Scott Smith, director of project management, CT, Philips Healthcare, describes low-dose CT as nearly a given in the marketplace now. What’s more important is maintaining the speed and quality of the image while using iterative reconstruction to keep the dose low.
iDose4 , he says, keeps the natural appearance of the object, despite its use of iterative reconstruction technology (see chest image to left), and keeps up the speed needed to make CT useful in trauma settings.
“The majority of reconstruction images happen in under 60 seconds,” Scott says.
Philips also will present its Ingenuity CT products as a suite, a sort of continuum of increasing sophistication. Scott describes it as “investment protection,” since customers can upgrade in-room.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
July 31st 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 31st 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.